Oral and fecal microbiota in patients with diarrheal irritable bowel syndrome

被引:9
|
作者
Tang, Binbin [1 ,2 ]
Hu, Yunlian [3 ,4 ]
Chen, Jianhui [3 ,4 ]
Su, Chengxia [3 ,4 ]
Zhang, Qian [3 ,4 ]
Huang, Chaoqun [3 ,4 ]
机构
[1] Tongde Hosp Zhejiang Prov, Outpatient Dept 2, Hangzhou, Peoples R China
[2] Hubei Univ Chinese Med, Clin Coll Tradit Chinese Med, Wuhan, Peoples R China
[3] Hubei Prov Hosp Tradit Chinese Med, Dept Gastroenterol, Wuhan, Peoples R China
[4] Hubei Univ Chinese Med, Clin Coll 1, Wuhan, Peoples R China
关键词
Fecal microbiota; Oral microbiota; Irritable bowel syndrome; Diarrhea; INFLAMMATION;
D O I
10.1016/j.heliyon.2023.e13114
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Background: This study aimed at investigating the characteristics and correlation between oral (tongue coating) and fecal microbiota in patients with diarrheal irritable bowel syndrome (IBS-D).Methods: Fifty-two IBS-D patients were chosen, with ten healthy volunteers serving as the normal control group. Tongue coating samples and fecal samples of subjects were sequenced for the 16S rRNA gene (V4-V5). Bioinformatics analysis was done on the test data to investigate oral and fecal microbiota composition characteristics in IBS-D patients.Results: The microbial richness of tongue coating in IBS-D group was lower than that in the normal control group (P < 0.05). The beta diversity of tongue coating microbiota and fecal microbiota was significantly different in the IBS-D group compared to the normal control group (P < 0.05). Pseudomonadales (Pseudomonadaceae and Pseudomonas), Moraxellaceae, Parvimonas, Peptos-treptococcus, and Alloprevotella were considerably high in number the tongue coating samples of the IBS-D group in comparison to the normal control group. Similarly, the fecal samples from the IBS-D group were significantly enriched in Alphaproteobacteria, Pseudomonadales (Pseudomona-daceae and Pseudomonas), Acidaminococcaceae, Phascolarctobacterium, Alloprevotella, and Escher-ichia compared to the normal control group.Conclusions: The oral and fecal microbiotas of IBS-D patients differ from those of the control group; hence studying IBS-D from the perspective of the oral-gut microbiome axis is an interesting research avenue.
引用
收藏
页数:10
相关论文
共 50 条
  • [41] Prokaryotic and Eukaryotic Fecal Microbiota in Irritable Bowel Syndrome Patients and Healthy Individuals Colonized With Blastocystis
    Nourrisson, Celine
    Scanzi, Julien
    Brunet, Julie
    Delbac, Frederic
    Dapoigny, Michel
    Poirier, Philippe
    FRONTIERS IN MICROBIOLOGY, 2021, 12
  • [42] Treatment of irritable bowel syndrome with fecal microbiota transplantation by colonoscopy: A case series of ten patients
    Hong, Ji Taek
    Bang, Byoung Wook
    Shin, Yong Woon
    Kim, Hyung Gil
    Kwon, Kye Sook
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2017, 32 : 145 - 146
  • [43] Evidence of altered mucosa-associated and fecal microbiota composition in patients with Irritable Bowel Syndrome
    Sundin, Johanna
    Aziz, Imran
    Nordlander, Sofia
    Polster, Annikka
    Hu, Yue O. O.
    Hugerth, Luisa W.
    Pennhag, Alexandra A. L.
    Engstrand, Lars
    Tornblom, Hans
    Simren, Magnus
    Ohman, Lena
    SCIENTIFIC REPORTS, 2020, 10 (01)
  • [44] Changes in colonic enteroendocrine cells of patients with irritable bowel syndrome following fecal microbiota transplantation
    Mazzawi, Tarek
    Hausken, Trygve
    El-Salhy, Magdy
    SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2022, 57 (07) : 792 - 796
  • [45] Evidence of altered mucosa-associated and fecal microbiota composition in patients with Irritable Bowel Syndrome
    Johanna Sundin
    Imran Aziz
    Sofia Nordlander
    Annikka Polster
    Yue O. O. Hu
    Luisa W. Hugerth
    Alexandra A. L. Pennhag
    Lars Engstrand
    Hans Törnblom
    Magnus Simrén
    Lena Öhman
    Scientific Reports, 10
  • [46] Long-term effects of fecal microbiota transplantation (FMT) in patients with irritable bowel syndrome
    El-Salhy, Magdy
    Kristoffersen, Anja Brathen
    Valeur, Jorgen
    Casen, Christina
    Hatlebakk, Jan Gunnar
    Gilja, Odd Helge
    Hausken, Trygve
    NEUROGASTROENTEROLOGY AND MOTILITY, 2022, 34 (01):
  • [47] Efficacy of Fecal Microbiota Transplantation for Patients With Irritable Bowel Syndrome at 3 Years After Transplantation
    El-Salhy, Magdy
    Winkel, Renate
    Casen, Christina
    Hausken, Trygve
    Gilja, Odd Helge
    Hatlebakk, Jan Gunnar
    GASTROENTEROLOGY, 2022, 163 (04) : 982 - +
  • [48] FECAL MICROBIOTA TRANSPLANTATION FOR PATIENTS WITH IRRITABLE BOWEL SYNDROME: A SYSTEMATIC REVIEW AND META-ANALYSIS
    Pan, Fei
    Zhao, Huijun
    GASTROENTEROLOGY, 2021, 160 (06) : S572 - S573
  • [49] Item-Level Assessment of the Irritable Bowel Syndrome Quality of Life Questionnaire in Patients With Diarrheal Irritable Bowel Syndrome
    Andrae, David A.
    Covington, Paul S.
    Patrick, Donald L.
    CLINICAL THERAPEUTICS, 2014, 36 (05) : 663 - 679
  • [50] Microbiota and the irritable bowel syndrome
    Sabo, Cristina M.
    Dumitrascu, Dan L.
    MINERVA GASTROENTEROLOGY, 2021, 67 (04): : 377 - 384